Biotech Ayala Pharmaceuticals to Accelerate Development of AL102 for the Treatment of Desmoid Tumors in Pivotal Phase 2/3 Study January 4, 2021
Biotech ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV(TM) January 4, 2021
Biotech Allena Pharmaceuticals to Present at Upcoming Investor Conferences in January January 4, 2021
Biotech Arbutus to Participate in Virtual Fireside Chat at H.C. Wainwright BioConnect 2021 Conference January 4, 2021
Biotech Matinas BioPharma Announces FDA Conditional Acceptance of LYPDISO(TM) as the Brand Name for MAT9001 January 4, 2021
Biotech AzurRx BioPharma Announces Exclusive Worldwide License Agreement with First Wave Bio for Use of Proprietary Niclosamide Formulations to Treat Immune Checkpoint Inhibitor-Associated Colitis and COVID-19 Gastrointestinal Infections January 4, 2021
Biotech EyePoint Pharmaceuticals Announces $15.7 Million Equity Investment by Asia Partner Ocumension Therapeutics January 3, 2021